<DOC>
	<DOCNO>NCT02652663</DOCNO>
	<brief_summary>Magnetic resonance imaging ( MRI ) widely use problem-solving tool evaluation hepatic lesion , show well sensitivity CT detection colorectal liver metastasis , especially lesion small 1 cm . After introduction liver-specific hepatobiliary MR contrast agent , gadoxetic acid , gadoxetic acid-enhanced MRI ( Gd-EOB-MRI ) increasingly use evaluation liver lesion include CRLM . However , compare conventional MRI extracellular contrast agent ( ECA-MRI ) , Gd-EOB-MRI different pharmacodynamic characteristic , expensive due high cost gadoxetic acid need longer scan time obtain hepatobiliary phase generally acquire 15 20 minute contrast injection . The purpose study compare clinical outcome diagnostic performance Gd-EOB-MRI ECA-MRI evaluation focal hepatic lesion newly diagnose colorectal cancer .</brief_summary>
	<brief_title>Liver MRI Colorectal Cancer Liver Metastasis : Comparative Effectiveness Research Choice Contrast Agents</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>1. patient surgically proven colorectal adenocarcinoma 2. patient underwent abdominopelvic CT liver MRI initial stag treatment 3. past concurrent malignancy colorectal adenocarcinoma . 1. precontrast abdominopelvic CT 2. precontrast liver MRI 3. liver MRI use contrast extracellular agent gadoxetic acid 4. interval CT liver MRI longer 4 week 5. patient suspected multiple hepatic metastasis ( &gt; 10 ) CT 6. distant metastasis liver 7. unavailable reference standard hepatic lesion pathologic confirmation follow imaging .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>liver</keyword>
	<keyword>MRI</keyword>
	<keyword>contrast</keyword>
	<keyword>gadoxetic acid</keyword>
</DOC>